Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Nureca Ltd Performance

Today's Low
268.50
arrowIcon
Today's High
272.85
52 Wk Low
253.50
arrowIcon
52 Wk High
468.80


Open

268.5

Traded Value (Cr)

15.01 L

Prev. Close

268.45

VWAP

272.1

Volume

11,266

Face Value

10

Nureca Ltd Fundamentals

Market Cap
₹ 277 Cr
P/E Ratio (TTM)
338.84
P/B Ratio
1.41
Debt to Equity
0.01
ROE
0.49 %
EPS (TTM)
0.82
Dividend Yield
0.00%
Book Value
197.04

Click here to know more about Fundamentals

Nureca Ltd Financials

Nureca Ltd Financials

Nureca Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 63.24 % 63.24 % 63.24 % 62.98 %
Retail 33.73 % 33.61 % 34.32 % 34.24 %
Others 2.96 % 3.08 % 2.34 % 2.68 %
FII 0.08 % 0.08 % 0.10 % 0.10 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

63.24%

Retail

33.73%

Others

2.96%

FII

0.08%

Mutual Funds

0.00%

Promoters

63.24%

Retail

33.61%

Others

3.08%

FII

0.08%

Mutual Funds

0.00%

Promoters

63.24%

Retail

34.32%

Others

2.34%

FII

0.10%

Mutual Funds

0.00%

Promoters

62.98%

Retail

34.24%

Others

2.68%

FII

0.10%

Mutual Funds

0.00%

Resistance and Support

₹277.75

PIVOT

resistance-arrow
Resistance
First Resistance₹281.250
Second Resistance₹284.300
Third Resistance₹287.800
support-arrow
Support
First Resistance₹274.700
Second Resistance₹271.200
Third Resistance₹268.150
RSI42.972
MACD-2.809
ADX12.819
CCI-171.227

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day11,2667,66168.00
Week13,1598,03559.95
1 Month22,43113,17961.40
6 Months7,7443,73548.23

About Nureca Ltd

The Company was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. The Company is engaged in the business of home healthcare and wellness products. The Company is a leading healthcare and wellness company with a product range of over 150 SKUs across different categories. The flagship brands such as Dr. Trust continue to enjoy high credibility and a loyal customer base. The products comply with USFDA, European CE, ROHS and ISO certifications, which reinforce customer's belief in their products. At present, the Company holds more than 100 design products. Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company is committed to creating products that support diagnosis, treatment and prevention of illness through monitoring and analysis of health data. Nureca's products are manufactured to be safe, accurate, long-lasting, and compliant with national and international regulations. The Company's growing range of connected devices is well entrenched in IoT and easy to sync with smart devices, while health app provides secure consolidation of data. The Company is focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives. The Company envisaged digital ecosystem and principles aims to provide integrated solutions aiding customers to maintain a suitable fitness regime, have clear understanding of and control over existing diseases with easier health monitoring at home and optimum nutrition through quality nutraceuticals. In 2017, the Company commenced business operations and launched 'Dr. Trust' brand through digital healthcare channel. In 2018, the Company widened product basket with launching of brands in electric massages and mother & child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh. In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Company's key products secured a warehouse drug license. In 2020, Company expanded presence through different channels and took initiative for starting business with 1mg, Pharmeasy, Paytm, and Croma retail stores. The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited (demerged company) and Nureca Private Limited (resulting company) and their respective shareholders and creditors under Section 230 to 232 and other applicable provisions of the Companies Act 2013, which has been sanctioned by the Honorable National Company Law Tribunal (NCLT), Mumbai vide its Order dated 29 April 2020. The Scheme had become effective on 23 May 2020 (Effective date) on filing of certified copy of the Order with the Registrar of Companies. The Appointed Date from which the Scheme was operative was 1 April 2019. Pursuant to the Scheme of Demerger, certain portion of business activities of the demerged company was transferred by Nectar Biopharma Private Limited from the Appointed date of 1 April 2019. In FY 2021, the Company received prestigious 'Economic Times Best Healthcare Brands Award 2021'.

Managing Director

Saurabh Goyal

Founded

2016

NSE Symbol

NURECA

Nureca Ltd Management

NameDesignation
Saurabh GoyalChairman & Managing Director
Vijay Kumar SharmaIndependent Director
Charu SinghIndependent Director
Ruchita AgarwalIndependent Director
Vikram ChaudharyIndependent Director
Chetna AnandCompany Sec. & Compli. Officer
Aryan GoyalWhole Time Director & CEO

Nureca Ltd News

Nureca to table results
On 15 May 2024
Nureca consolidated net profit declines 43.33% in the December 2023 quarter
Sales decline 19.50% to Rs 22.37 crore
Nureca to hold board meeting
On 7 February 2024
Nureca reports consolidated net profit of Rs 2.89 crore in the September 2023 quarter
Sales decline 14.76% to Rs 31.35 crore
Nureca announces board meeting date
On 4 November 2023
Nureca reports consolidated net loss of Rs 0.71 crore in the June 2023 quarter
Sales decline 16.84% to Rs 21.23 crore
Nureca to discuss results
On 10 August 2023
Nureca to conduct AGM
On 20 July 2023
Nureca reports standalone net loss of Rs 1.80 crore in the March 2023 quarter
Sales decline 48.34% to Rs 21.22 crore
Nureca reports consolidated net loss of Rs 1.53 crore in the March 2023 quarter
Sales decline 48.28% to Rs 21.23 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
ZOMATO₹ 1,72,206 Cr
₹ 195.25
(-0.10 %)
149.08
NAUKRI₹ 77,010 Cr
₹ 5,952.05
(-0.80 %)
93.94
NYKAA₹ 48,098 Cr
₹ 168.40
(-1.43 %)
0.00
PAYTM₹ 21,168 Cr
₹ 333.00
(5.00 %)
0.00
INDIAMART₹ 15,864 Cr
₹ 2,645.00
(-2.67 %)
43.77

Nureca Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Nureca Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Nureca Ltd's share price is ₹271.65 as of May 10, 2024

Nureca Ltd's P/E ratio is 338.84 times as of May 10, 2024.

Nureca Ltd's most recent financial reports indicate a price-to-book ratio of 1.41, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Nureca Ltd's market is 278 Cr as on May 10, 2024.

The current financial records of Nureca Ltd show a 0.49% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Nureca Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Nureca Ltd's 52-week high and low as of May 10, 2024 are ₹272.85 and ₹268.5 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Nureca Ltd stands at 63.24%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.08% to 0.08%.